PLOD1 and obesity due to melanocortin 4 receptor deficiency: This study raises the possibility of LH use as a beneficial treatment for obesity, but more systematic work is warranted to elucidate the health benefits of LH in humans, which requires in vitro experiments in the human gut model or clinical trials before its applications as a routine therapy.